Scynexis (SCYX) Equity Average (2014 - 2026)
Scynexis (SCYX) reported Equity Average of $45.3 million for Q1 2026, down 14.13% on a YoY basis from $52.8 million in Q1 2025, and up 5.68% quarter-over-quarter from $42.9 million in Q4 2025.
Scynexis (SCYX) Equity Average (2014 - 2026) Analysis & Trends
Scynexis has reported Equity Average for 13 years, with the latest figure at $45.3 million in Q1 2026.
- For the quarter ending Q1 2026, Equity Average fell 14.13% year-over-year to $45.3 million; the trailing twelve-month figure through Mar 2026 stood at $45.3 million (down 14.13% YoY), and the FY2025 full-year result was $52.2 million, down 18.42% from the prior year.
- Equity Average for Q1 2026 stood at $45.3 million, up from $42.9 million in the prior quarter.
- The five-year high for Equity Average was $92.5 million in Q3 2023, with the low at -$13.3 million in Q1 2023.
- Historically, Equity Average has averaged $47.2 million across 5 years, with a median of $45.3 million in 2026.
- The largest YoY upside for Equity Average was 706.93% in 2023 against a maximum downside of 133.27% in 2023.
- Scynexis' Equity Average stood at $10.2 million in 2022, then jumped by 706.93% to $82.5 million in 2023, then slumped by 31.13% to $56.8 million in 2024, then retreated by 24.47% to $42.9 million in 2025, then rose by 5.68% to $45.3 million in 2026.
- The last three Equity Average figures came in at $45.3 million (Q1 2026), $42.9 million (Q4 2025), and $40.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 8.07 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 3.32 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 6.50 Bn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 409.63 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 3.33 Bn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 6.52 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 1.79 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 493.55 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 1.15 Bn |
| 10 | Scynexis | 225.23 Mn | 165.97 Mn | - | 45.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 45.34 Mn |
| Dec 31, 2025 | 42.90 Mn |
| Sep 30, 2025 | 40.45 Mn |
| Jun 30, 2025 | 47.50 Mn |
| Mar 31, 2025 | 52.80 Mn |
| Dec 31, 2024 | 56.80 Mn |
| Sep 30, 2024 | 59.47 Mn |
| Jun 30, 2024 | 67.26 Mn |
| Mar 31, 2024 | 73.53 Mn |
| Dec 31, 2023 | 82.48 Mn |
| Sep 30, 2023 | 92.53 Mn |
| Jun 30, 2023 | 31.58 Mn |
| Mar 31, 2023 | -13.34 Mn |
| Dec 31, 2022 | 10.22 Mn |
| Sep 30, 2022 | 31.34 Mn |
| Jun 30, 2022 | 42.20 Mn |
| Mar 31, 2022 | 40.09 Mn |
| Dec 31, 2021 | 39.44 Mn |
| Sep 30, 2021 | 34.97 Mn |
| Jun 30, 2021 | 29.12 Mn |